# Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas

> **NCT06863805** · — · RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 10 (estimated)

## Conditions studied

- Thyroid Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** 4 EDTA tubes of peripheral blood for Multigene analysis on ccf-DNA and ccf-RNA

## Key facts

- **NCT ID:** NCT06863805
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06863805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06863805, "Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06863805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*